Undiagnosed cardiovascular risk factors in overweight and obese individuals: a low income country experience

被引:0
作者
Alfredo Vallejo-Valdivieso, Patricio [1 ]
Zambrano-Pincay, Graciela [1 ]
Ortiz, Alberto [2 ]
机构
[1] Univ Tecn Manabi, Fac Ciencias Salud, Portoviejo, Ecuador
[2] Univ Autonoma Madrid, Nephrol & Hypertens, Inst Invest Sanitaria, Fdn Jimenez Diaz, Madrid, Spain
关键词
Obesity; Overweight; Global burden of disease; Diabetes; Albuminuria; Chronic kidney disease; Low-income; Epidemiology; Undiagnosed; Hypertension; PREVALENCE; ADULTS;
D O I
10.7717/peerj.10870
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background. Overweight and obesity are associated with diabetes, hypertension and chronic kidney disease (CKD). However, there is scarce information from lower income countries about undiagnosed obesity-associated conditions. This information is necessary for healthcare planning and for assessment of Global Burden of Disease. Methods. We assessed the prevalence of obesity-associated conditions in 656 overweight (n = 360) and obese (n = 296) adults from inner-city Portoviejo (Ecuador), in descriptive field research, based on an opportunistic and selective sampling strategy. Results. Of 316 men and 340 women, 73% met criteria for prehypertension (27%) or hypertension (46%), 50% met criteria for prediabetes (30%) or diabetes (20%), 11% had an estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m(2) consistent with chronic kidney disease (CKD) and 5.5% had pathological albuminuria for a total CKD prevalence of 16%. Age-related prevalence data were generated. In all participants, serum total cholesterol and triglycerides were >200 and >150 mg/dl, respectively. Hyperuricemia and microhematuria (<2%) were uncommon. Women were more likely to have low eGFR (18 vs 5%, p 0.000). Diabetes and pathological albuminuria prevalence were higher in obese than in overweight participants (15 vs 12%, p 0.018; and 8 vs 4%, p 0.0199, respectively). Discussion. In conclusion, undiagnosed hypertension, diabetes and CKD were more common than expected in overweight and obese persons from Ecuador. Detection rates exceeded official estimates of prevalene of these conditions. Screening the overweight/obese for these conditions, especially at the age ranges at higher risk, may be cost-effective to identify a high number of persons who may benefit from early inexpensive intervention.
引用
收藏
页数:16
相关论文
共 26 条
[1]  
Abbafati C, 2020, LANCET, V396, P1204
[3]  
[Anonymous], 2020, POPULATION AGE GROUP
[4]  
Bravo Moreira CD, 2013, ANALISIS CALIDAD AGU
[5]   CKD Prevalence Varies across the European General Population [J].
Bruck, Katharina ;
Stel, Vianda S. ;
Gambaro, Giovanni ;
HaIlan, Stein ;
Volzke, Henry ;
Arnlov, Johan ;
Kastarinen, Mika ;
Guessous, Idris ;
Vinhas, Jose ;
Stengel, Benedicte ;
Brenner, Hermann ;
Chudek, Jerzy ;
Romundstad, Solfrid ;
Tomson, Charles ;
Otero Gonzalez, Alfonso ;
Bello, Aminu K. ;
Ferrieres, Jean ;
Palmieri, Luigi ;
Browne, Gemma ;
Capuano, Vincenzo ;
Van Biesen, Wim ;
Zoccali, Carmine ;
Gansevoort, Ron ;
Navis, Gerjan ;
Rothenbacher, Dietrich ;
Ferraro, Pietro Manuel ;
Nitsch, Dorothea ;
Wanner, Christoph ;
Jager, Kitty J. ;
Consortium, European C. K. D. Burden .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (07) :2135-2147
[6]   PREVALENCE OF HYPERTENSION IN THE US ADULT-POPULATION - RESULTS FROM THE 3RD NATIONAL-HEALTH AND NUTRITION EXAMINATION SURVEY, 1988-1991 [J].
BURT, VL ;
WHELTON, P ;
ROCCELLA, EJ ;
BROWN, C ;
CUTLER, JA ;
HIGGINS, M ;
HORAN, MJ ;
LABARTHE, D .
HYPERTENSION, 1995, 25 (03) :305-313
[7]   Dietary Care for ADPKD Patients: Current Status and Future Directions [J].
Carriazo, Sol ;
Vanessa Perez-Gomez, Maria ;
Cordido, Adrian ;
Angel Garcia-Gonzalez, Miguel ;
Belen Sanz, Ana ;
Ortiz, Alberto ;
Dolores Sanchez-Nino, Maria .
NUTRIENTS, 2019, 11 (07)
[8]  
Central Intelligence Agency, 2020, ECUADOR
[9]   SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemia [J].
Fernandez-Fernandez, Beatriz ;
Sarafidis, Pantelis ;
Kanbay, Mehmet ;
Navarro-Gonzalez, Juan F. ;
Jose Soler, Maria ;
Luis Gorriz, Jose ;
Ortiz, Alberto .
CLINICAL KIDNEY JOURNAL, 2020, 13 (05) :728-733
[10]   Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan? [J].
Fernandez-Fernandez, Beatriz ;
Fernandez-Prado, Raul ;
Luis Gorriz, Jose ;
Martinez-Castelao, Alberto ;
Navarro-Gonzalez, Juan F. ;
Porrini, Esteban ;
Jose Soler, Maria ;
Ortiz, Alberto .
CLINICAL KIDNEY JOURNAL, 2019, 12 (03) :313-321